Home > Publications database > Membrane potentials regulating GPCRs: insights from experiments and molecular dynamics simulations > print |
001 | 836022 | ||
005 | 20210129230850.0 | ||
024 | 7 | _ | |a 10.1016/j.coph.2016.06.011 |2 doi |
024 | 7 | _ | |a 1471-4892 |2 ISSN |
024 | 7 | _ | |a 1471-4973 |2 ISSN |
024 | 7 | _ | |a 2128/15002 |2 Handle |
024 | 7 | _ | |a WOS:000386861200009 |2 WOS |
024 | 7 | _ | |a altmetric:10150444 |2 altmetric |
024 | 7 | _ | |a pmid:27474871 |2 pmid |
037 | _ | _ | |a FZJ-2017-05147 |
041 | _ | _ | |a English |
082 | _ | _ | |a 340 |
100 | 1 | _ | |a Vickery, Owen N |0 P:(DE-HGF)0 |b 0 |
245 | _ | _ | |a Membrane potentials regulating GPCRs: insights from experiments and molecular dynamics simulations |
260 | _ | _ | |a Amsterdam [u.a.] |c 2016 |b Elsevier Science |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1501491432_31609 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a G-protein coupled receptors (GPCRs) form the largest class of membrane proteins in humans and the targets of most present drugs. Membrane potential is one of the defining characteristics of living cells. Recent work has shown that the membrane voltage, and changes thereof, modulates signal transduction and ligand binding in GPCRs. As it may allow differential signalling patterns depending on tissue, cell type, and the excitation status of excitable cells, GPCR voltage sensitivity could have important implications for their pharmacology. This review summarises recent experimental insights on GPCR voltage regulation and the role of molecular dynamics simulations in identifying the structural basis of GPCR voltage-sensing. We discuss the potential significance for drug design on GPCR targets from excitable and non-excitable cells. |
536 | _ | _ | |a 551 - Functional Macromolecules and Complexes (POF3-551) |0 G:(DE-HGF)POF3-551 |c POF3-551 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Machtens, Jan-Philipp |0 P:(DE-Juel1)156429 |b 1 |u fzj |
700 | 1 | _ | |a Zachariae, Ulrich |0 P:(DE-HGF)0 |b 2 |e Corresponding author |
773 | _ | _ | |a 10.1016/j.coph.2016.06.011 |g Vol. 30, p. 44 - 50 |0 PERI:(DE-600)2038524-9 |p 44 - 50 |t Current opinion in pharmacology |v 30 |y 2016 |x 1471-4892 |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/836022/files/1-s2.0-S1471489216300601-main.pdf |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/836022/files/1-s2.0-S1471489216300601-main.gif?subformat=icon |x icon |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/836022/files/1-s2.0-S1471489216300601-main.jpg?subformat=icon-1440 |x icon-1440 |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/836022/files/1-s2.0-S1471489216300601-main.jpg?subformat=icon-180 |x icon-180 |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/836022/files/1-s2.0-S1471489216300601-main.jpg?subformat=icon-640 |x icon-640 |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/836022/files/1-s2.0-S1471489216300601-main.pdf?subformat=pdfa |x pdfa |y OpenAccess |
909 | C | O | |o oai:juser.fz-juelich.de:836022 |p openaire |p open_access |p driver |p VDB |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)156429 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |1 G:(DE-HGF)POF3-550 |0 G:(DE-HGF)POF3-551 |2 G:(DE-HGF)POF3-500 |v Functional Macromolecules and Complexes |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
914 | 1 | _ | |y 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CURR OPIN PHARMACOL : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)ICS-4-20110106 |k ICS-4 |l Zelluläre Biophysik |x 0 |
980 | 1 | _ | |a FullTexts |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-Juel1)ICS-4-20110106 |
981 | _ | _ | |a I:(DE-Juel1)IBI-1-20200312 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|